ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 235,61
0,07%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) Actualités

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CLSD
DateHeureSourceTitreSymboleSociété
12/06/202413h05GlobeNewswire Inc.Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit MeetingNASDAQ:CLSDClearside Biomedical Inc
21/05/202413h05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
10/05/202422h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
09/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
09/05/202422h05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/05/202422h15GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
30/04/202413h05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
16/04/202413h05GlobeNewswire Inc.Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
02/04/202413h05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
18/03/202412h05GlobeNewswire Inc.Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical OfficerNASDAQ:CLSDClearside Biomedical Inc
12/03/202421h05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
29/02/202413h05GlobeNewswire Inc.Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024NASDAQ:CLSDClearside Biomedical Inc
08/02/202422h52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLSDClearside Biomedical Inc
07/02/202414h00GlobeNewswire Inc.Clearside Biomedical Announces Pricing of $15 Million Registered Direct OfferingNASDAQ:CLSDClearside Biomedical Inc
20/01/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
19/01/202421h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLSDClearside Biomedical Inc
14/12/202313h05GlobeNewswire Inc.Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
13/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
13/11/202322h05GlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/11/202313h05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
07/11/202322h20GlobeNewswire Inc.Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
03/11/202317h00GlobeNewswire Inc.BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®NASDAQ:CLSDClearside Biomedical Inc
02/11/202312h05GlobeNewswire Inc.Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
01/11/202312h05GlobeNewswire Inc.Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
31/10/202312h05GlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023NASDAQ:CLSDClearside Biomedical Inc
16/10/202313h05GlobeNewswire Inc.Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific MeetingNASDAQ:CLSDClearside Biomedical Inc
04/10/202315h00GlobeNewswire Inc.Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific for Suprachoroidal Treatment of Uveitic Macular Edema as Partner Arctic Vision Completes Enrollment in Phase 3 Clinical Trial in ChinaNASDAQ:CLSDClearside Biomedical Inc
03/10/202322h35GlobeNewswire Inc.Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare SummitNASDAQ:CLSDClearside Biomedical Inc
19/09/202313h05GlobeNewswire Inc.Clearside Biomedical to Participate in Panel Discussion at the Cantor Global Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
14/08/202322h05GlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Dernières Valeurs Consultées

EU
B283
Belgium Domestic bond No...
LSE
72NB
Rep. China 51 S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés